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Phospholipids and fatty acids are not only one of the major components of cell
membranes but also important metabolic intermediates in bacteria. Since the fatty
acid biosynthetic pathway is essential and energetically expensive, organisms have
developed a diversity of homeostatic mechanisms to fine-tune the concentration of
lipids at particular levels. FapR is the first global regulator of lipid synthesis discovered
in bacteria and is largely conserved in Gram-positive organisms including important
human pathogens, such as Staphylococcus aureus, Bacillus anthracis, and Listeria
monocytogenes. FapR is a transcription factor that negatively controls the expression
of several genes of the fatty acid and phospholipid biosynthesis and was first identified in
Bacillus subtilis. This review focuses on the genetic, biochemical and structural advances
that led to a detailed understanding of lipid homeostasis control by FapR providing
unique opportunities to learn how Gram-positive bacteria monitor the status of fatty acid
biosynthesis and adjust the lipid synthesis accordingly. Furthermore, we also cover the
potential of the FapR system as a target for new drugs against Gram-positive bacteria
as well as its recent biotechnological applications in diverse organisms.
Keywords: lipid synthesis, FapR, transcriptional regulation, Gram-positive bacteria, in vivo malonyl-CoA sensor,
synthetic biology
INTRODUCTION
The cell membrane, consisting mainly of a fluid phospholipid bilayer in which a variety of
proteins are embedded, is an essential structure to bacteria making membrane lipid homeostasis
a crucial aspect of bacterial cell physiology. The production of phospholipids requires of the
biosynthesis of fatty acids and their subsequent delivery to the membrane-bound glycerol-
phosphate acyltransferases. In all organisms fatty acids are synthetized via a repeated cycle of
reactions involving the condensation, reduction, hydration, and reduction of carbon-carbon bonds
(Rock and Cronan, 1996; Campbell and Cronan, 2001). In mammals and other higher eukaryotes,
these reactions are all catalyzed by a largemultifunctional protein, known as type I synthase (FAS I),
in which the growing fatty acid chain is covalently attached to the protein (Rock and Cronan, 1996;
Campbell and Cronan, 2001). In contrast, bacteria, plant chloroplasts, and Plasmodium falciparum
contain a type II system (FAS II) in which each reaction is catalyzed by a discrete protein. A
characteristic of FASII is that all fatty acyl intermediates are covalently connected to a small acidic
protein named acyl carrier protein (ACP), and sequentially shuttled from one enzyme to another.
A key molecule for fatty acid elongation is malonyl—coenzyme A (CoA) which is formed by
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carboxylation of acetyl-CoA by the enzyme acetyl-CoA
carboxylase (ACC) (Figure 1). This biosynthetic scheme is
conserved in all fatty acid producing bacteria, but the substrate
specificity of some of the enzymes involved in the pathway
leads to the variety of fatty acids found in different bacterial
genera (Campbell and Cronan, 2001; Lu et al., 2004). When the
acyl-ACPs reach the proper length they become substrates for
the acyltransferases that transfer successively the fatty acyl chains
into glycerol phosphate to synthetize phosphatidic acid (PtdOH),
the universal intermediate in the biosynthesis of membrane
glycerophospholipids (Figure 1: Campbell and Cronan, 2001;
Rock and Jackowski, 2002). There are two enzyme systems that
carry out the first transacylation reaction in bacteria. In the first
one, present exclusively in Gram-negative bacteria (primarily
gamma-proteobacteria), either acyl-ACP or acyl-CoA thioesters
are utilized by the membrane-bound PlsB acyltransferase to
acylate position 1 of glycerol-P giving 1-acylglycerol phosphate
(Parsons and Rock, 2013). The second enzyme system, widely
distributed and predominating in Gram-positive bacteria, consist
of the PlsX/Y pathway for 1-acyl-glycerol phosphate formation
(Lu et al., 2006; Schujman and de Mendoza, 2006; Paoletti et al.,
2007). PlsX is a membrane associated protein (Sastre et al., 2016)
that catalyzes the formation of a novel acyl donor, acyl phosphate
(acyl-P), from acyl-ACP. This activated fatty acid is then used
by the membrane-bound PlsY acyl transferase to acylate the
position 1 of glycerol phosphate. The PlsX/PlsY system is also
present in E. coli although its precise role is still an enigma as
plsB is an essential gene in this bacterium (Parsons and Rock,
2013). Independently of the first enzyme system used, the second
acyl transferase in PtdOH formation is PlsC, which is universally
expressed in bacteria. This enzyme completes the synthesis
of PtdOH by transferring an acyl chain to the position 2 of
1-acyl-glycerol phosphate. In the case of Gram-positive bacteria,
PlsC isoforms exclusively utilize acyl-ACP (Lu et al., 2006;
Paoletti et al., 2007), while E. coli PlsC can use both, acyl-ACP or
acyl-CoA, as substrates (Coleman, 1992).
The fluidity of the lipid bilayer is essential for the normal
function of the cellular membrane and bacteria normally
control its physical state by modifying the incorporation of
a mixture of fatty acids with different melting temperatures
into phospholipids. In this sense, many bacteria respond to a
decrease in temperature, which increases membrane rigidity,
by increasing the proportion of unsaturated fatty acids (UFAs)
into the phospholipids and viceversa (Zhang and Rock, 2008).
Unsaturated double bonds in lipids generate kinks into the
otherwise straightened acyl hydrocarbon chain and thereby
increase membrane fluidity. Hence, the production of UFAs and
its regulation are important processes in membrane homeostasis
in bacteria and the underlying diverse mechanisms have been
recently revised elsewhere (Mansilla et al., 2008; Parsons and
Rock, 2013).
Due to the fact that the membrane lipid bilayer is an
essential structure for every living cell and its biogenesis implies
a high energetic cost, mainly due to fatty acid biosynthesis,
organisms have developed a variety of homeostatic mechanisms
to finely adjust the concentration of lipids at particular levels.
Bacteria possess regulatory mechanisms acting directly on
the activities of the lipid biosynthetic enzymes, but have
also evolved sophisticated mechanisms to exert an exquisite
control over the expression of the genes involved in lipid
metabolism (Zhang and Rock, 2008; Parsons and Rock, 2013).
Six transcriptional regulators controlling the expression of genes
involved in fatty acid biosynthesis have been identified to date
in bacteria. Among them, FadR (Henry and Cronan, 1991,
1992; Lu et al., 2004), DesR (Aguilar et al., 2001; Mansilla
and de Mendoza, 2005), FabR (Zhang et al., 2002), and DesT
(Zhu et al., 2006; Zhang et al., 2007), are committed to
adjust unsaturated fatty acids to proper levels in membrane
phospholipids while FapR (Schujman et al., 2003) and FabT (Lu
and Rock, 2006) are global transcriptional repressors in Gram-
positive bacteria that simultaneously regulate the expression of
a number of genes involved in fatty acid and phospholipid
metabolism.
This review focuses on the genetic, biochemical and structural
characterization of FapR which paved the way to a major
advance in our understanding of the molecular basis of the
lipid homeostasis control in bacteria. We will also cover the
potential of this regulatory system as a target for new antibacterial
compounds as well as emerging biotechnological applications
based on it.
THE DISCOVERY OF THE FapR SYSTEM
FapR from Bacillus subtilis was the first global transcriptional
regulator of FASII to be discovered in bacteria (Schujman et al.,
2003). The initial evidence that fatty acid biosynthesis was
transcriptionally regulated came from the study of lacZ fusions
to the promoter region of the fabHAF operon of B. subtilis, which
codes for two key enzymes involved in the elongation of fatty
acids (Schujman et al., 2001). These studies showed that the
operon fabHAF is transcribed during exponential phase but when
the cell culture approaches to stationary phase its transcription
is turned off (Schujman et al., 2001). This finding is consistent
with the observation that during exponential growth bacteria
constantly produce new membrane in order to divide and hence
need to actively synthetize fatty acids. Nevertheless, when cell
division is completed membrane growth stops and fatty acid
synthesis is turned off. An important finding was that when fatty
acid synthesis is inhibited the transcription of the fabHAF operon
is induced with the concomitant increment in protein levels
(Schujman et al., 2001). Thus, it was proposed that B. subtilis
is able to detect a decrease in the activity of FASII and respond
accordingly by inducing the production of the condensing
enzymes FabHA and FabF (Schujman et al., 2001). Moreover,
DNA microarray studies indicated that upon inhibition of
fatty acid synthesis the transcription of ten genes was induced
(Schujman et al., 2003). These genes coded for proteins involved
in fatty acid and phospholipid biosynthesis and belonged to six
operons (the fap regulon) (Schujman et al., 2003). Furthermore,
a conserved 17 bp inverted repeat within, or immediately
downstream, of the fap predicted promoters, consistent with a
putative binding site for a transcriptional repressor, was identified
(Schujman et al., 2003). The corresponding binding protein
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FIGURE 1 | Fatty acid synthesis and phospholipid initiation steps in Bacillus subtilis. Malonyl-CoA is generated from acetyl-CoA by acetyl-CoA carboxylase
(ACC) (1) and then is transferred to ACP by malonyl-CoA transacylase (2). The FabH condensing enzymes initiates the cycles of fatty acid elongation by condensation
of acyl-CoA primers with malonyl-ACP (3a). The resultant β-ketoester is reduced by the β-ketoacyl-ACP reductase (4). Then, the β-hydroxyacyl-ACP is dehydrated to
the trans-2 unsaturated acyl-ACP by β-hydroxyacyl-ACP dehydrase (5), which is finally reduced by enoyl reductase (6). Subsequent rounds of elongation are initiated
by the elongation-condensing enzyme FabF (3b) to generate an acyl-ACP two carbons longer than the original acyl-ACP at the end of each cycle. The long chain
acyl-ACP end products of fatty acid synthesis are transacylated in three steps to glycerolphosphate, to generate phosphatidic acid (PA), a key intermediate in the
synthesis of phospholipids. First, PlsX catalyzes the synthesis of fatty acyl-phosphate from acyl-ACP (7); then, PlsY transfers the fatty acid from the activated acyl
intermediate to the 1-position of glycerol-3-phosphate (8) and finally, lyso-PA is acylated to PA by PlsC (9). Expression of the genes surrounded by shaded ellipses is
repressed by the transcriptional regulator FapR, whose activity is, in turn, antagonized by malonyl-CoA (enclosed in a red ellipse). R denotes the terminal group of
branched-chain or straight-chain fatty acids. Adapted from Albanesi et al. (2013).
was isolated from cells extracts using a DNA fragment carrying
the promoter region of fabHA and identified by N-terminal
sequencing (Schujman et al., 2003). The gene encoding the global
transcriptional repressor was named fapR for fatty acid and
phospholipid regulator (Schujman et al., 2003). The binding of
FapR to the promoter regions of the regulated genes, and its
dependence on the 17 inverted repeats was demonstrated in vitro.
It was also showed that in a fapR null mutant the expression
of the fap regulon is upregulated and that this expression is
not further increased upon inhibition of FASII (Schujman et al.,
2003). Therefore, it was established that FapR was a novel
global negative regulator of lipid biosynthesis in Gram-positive
bacteria and that FapR was involved in the observed induction of
transcription in the presence of fatty acids synthesis inhibitors
(Schujman et al., 2003). Bioinformatic analyses indicated that
FapR is present and highly conserved in all the species of
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the Bacillus, Listeria, and Staphylococcus genera (all including
important human pathogens like Bacillus anthracis, Bacillus
cereus, Listeria monocytogenes, and Staphylococcus aureus) as well
as in the pathogen Clostridium difficile and other related genera.
However, fapR was not found in Gram-negative bacteria or other
Gram-positive genera (Schujman et al., 2003). Furthermore,
in the bacterial species bearing FapR, the consensus binding
sequence for the repressor is also highly conserved in the putative
fapR promoter region. Altogether, the observations suggested
that the regulatory mechanism identified in B. subtilis could be
conserved inmany other bacteria (Schujman et al., 2003). Indeed,
genetic and biochemical assays proved this is the case in S. aureus
(Albanesi et al., 2013).
MALONYL-CoA: THE EFFECTOR
MOLECULE
A central question in the regulation of the fap regulon by
FapR was how the status of fatty acids synthesis controlled
the activity of the repressor. The fact that (i) the acc genes,
encoding the subunits of the acetyl-CoA carboxylase (ACC),
which catalyzes the synthesis of malonyl-CoA (Figure 1), are not
under FapR control (Schujman et al., 2003), (ii) malonyl-CoA
concentrations are known to increase upon inhibition of fatty
acid synthesis (Heath and Rock, 1995), and (iii) the only known
fate of malonyl-CoA in B. subtilis and most other bacteria is fatty
acid synthesis (James and Cronan, 2003), pointed to malonyl-
CoA as a reasonable candidate to be the regulatory ligand. Two
observations gave experimental support to this hypothesis. First,
expression of the fap regulon was derepressed by antibiotics
that inhibit fatty acid biosynthesis with the concomitant increase
in the intracellular levels of malonyl-CoA (Schujman et al.,
2001). Second, this upregulation was abolished by precluding the
transcription of genes encoding the subunits of the acetyl-CoA
carboxylase (ACC) (Schujman et al., 2003).
A key issue was to establish if malonyl-CoA bound directly
to FapR to regulate its activity or if it was first converted
into another product that acted as a signaling molecule. The
finding that antibiotics against different steps of FASII led to
the transcriptional induction of the fap regulon, even when
the B. subtilis fabD gene (Morbidoni et al., 1996) was not
expressed, suggested that malonyl-CoA could be the direct
effector of FapR (Schujman et al., 2003). FabD converts malonyl-
CoA into malonyl-ACP, which, in turn, is only utilized in the
elongation of fatty acid synthesis (de Mendoza et al., 2002).
In vitro transcription experiments from several promoters of
the fap regulon, including the fapR-operon promoter (PfapR),
proved that FapR is unable to repress transcription in the
presence of malonyl-CoA. Moreover, these assays showed that
this molecule operates not only as a direct but also as a specific
inducer of the fap promoters since different acyl-CoA derivatives
related to malonyl-CoA (such as acetyl-CoA, propionyl-CoA,
succinyl-CoA, and butyryl-CoA), were not able to prevent FapR
transcriptional repression (Schujman et al., 2003). The same
direct and specific role of malonyl-CoA as the effector molecule
was shown for FapR of S. aureus (SaFapR) (Albanesi et al., 2013).
STRUCTURAL SNAPSHOTS OF THE FapR
REGULATION CYCLE
Like many transcriptional regulators in bacteria, FapR is a
two-domain protein with an N-terminal DNA-binding domain
(DBD) connected through a linker α-helix (αL) to a larger
C-terminal effector-binding domain (EBD) (Schujman et al.,
2006). The first insights on the molecular mechanism for the
control of FapR activity came from the crystal structures of
truncated forms of FapR from B. subtilis (BsFapR) (Schujman
et al., 2006). These structures showed that the EBD is a symmetric
dimer displaying a “hot-dog” architecture, with two central
α-helices surrounded by an extended twelve-stranded β-sheet
(Schujman et al., 2006). This fold is similar to the one observed in
many homodimeric acyl-CoA-binding enzymes (Leesong et al.,
1996; Li et al., 2000) involved in fatty acid biosynthesis and
metabolism (Dillon and Bateman, 2004; Pidugu et al., 2009).
Interestingly, FapR, a bacterial transcriptional repressor, seems
to be the only well-characterized protein to date with no-
enzymatic function that harbors the “hot-dog” fold (Albanesi
et al., 2013). On the other hand, the EBD domain of BsFapR was
crystallized in complex with malonyl-CoA. Comparison of both
structures revealed structural changes induced by the effector
molecule in some ligand-binding loops of the EBD that were
suggested to propagate to the N-terminal DBDs impairing their
productive association for DNA binding (Schujman et al., 2006).
However, the actual mechanisms involved in the regulation of
FapR activity remained largely unknown due to the lack of
detailed structural information of the full-length repressor and its
complex with DNA. Recently, important mechanistic advances
into the mode of action of FapR were done through the structural
characterization of the full-length repressor from S. aureus
(SaFapR). The crystal structures of SaFapR were obtained for
the protein alone (apo-SaFapR) as well as in complex with the
cognate DNA operator and the effector molecule malonyl-CoA
(Albanesi et al., 2013) (Figure 2).
Structure of the SaFapR-DNA Complex
The crystal structure of the SaFapR-DNA complex was obtained
using a 40-bp oligonucleotide comprising the PfapR promoter,
which, as mentioned above, belongs to the fap regulon (Schujman
et al., 2006). In the crystal, two SaFapR homodimers were
observed to bind to each DNA molecule. Interestingly, an
inverted repeat covering half of the FapR-protected region
in DNAseI footprinting analyses (Schujman et al., 2006),
corresponded to the recognition site of one of the homodimers
(Albanesi et al., 2013). This suggested a sequential mechanism of
binding that was confirmed by isothermal titration calorimetry
(ITC) studies of the SaFapR-DNA interaction, which also
provided the dissociation constants of each binding reaction
(Albanesi et al., 2013). In the crystal structure of the SaFapR-
DNA complex, each protein homodimer exhibited an elongated
asymmetric conformation with the two DNA-bound DBDs
completely detached from the central dimeric “hot-dog” EBD
(Figure 2A) (Albanesi et al., 2013). In each homodimer the
amphipatic linker α-helixes from the protomers (αL and αL′)
interact, mainly through their exposed hydrophobic faces,
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FIGURE 2 | The transitional switch between the relaxed and tense states of FapR involves a significant structural rearrangement of the DBDs.
(A) Relaxed state: FapR in complex with DNA in which the amphipathic linker α-helix (αL) from each protomer associates with each other. (B) Tense state: FapR in
complex with malonyl-CoA (shown in stick representation). (C) Superposition of the two conformational states of the repressor illustrating the structural transition
which involves substantial changes and large (∼30 Å) inter-domain movements. Solvent accessible surfaces are shown in transparent to highlight the DNA-induced
dissociation of the invariant effector-binding domain (EBD) from the DNA-binding domains (DBDs). The molecules are shown in light (relaxed) and dark (tense) gray,
except for the helices from one DBD (colored). Adapted from Albanesi et al. (2013).
playing an important role in the stabilization of SaFapR’s
molecular architecture in the complex with DNA (Figure 2A)
(Albanesi et al., 2013). On their hand, both DBDs interact
in a similar manner with DNA establishing sequence-specific
contacts between the helix-turn-helix motifs with the major
and minor grooves of the DNA double helix (Albanesi et al.,
2013). Importantly, two arginine residues from each linker αL
(one from αL and one from αL′) make base-specific interactions
in the minor groove promoting its opening and inducing a
pronounced local bending of DNA (Albanesi et al., 2013).
Notably, the aminoacid residues making key contacts with
DNA are highly conserved in FapR from all bacterial species
where it was identified indicating the DNA-binding-mode of this
transcriptional repressor is conserved (Albanesi et al., 2013).
Structure of the SaFapR-Malonyl-CoA
Complex
The crystal structure of full-length SaFapR in complex with
malonyl-CoA showed that in the presence of the effector
molecule the repressor adopts a quaternary arrangement that
is different and more compact than when bound to DNA
(Figure 2B) (Albanesi et al., 2013). In this conformation, both
amphipathic linker helices αL bind to either side of the
central EBD domain instead of interacting with each other
as when binding DNA. Like this, the two DBDs domain
are far apart from each other, resulting in a non-productive
conformation incompetent to bind DNA. Stabilization of the
observed quaternary organization of the protein is principally
due to the interaction of the linker αL with the lateral face
of the EBD (Albanesi et al., 2013). Concerning ligand binding,
the structure showed that a tunnel is formed at the interface
between the two protomers in the SaFapR homodimer into which
the phosphopantetheine group is bound, adopting the same
conformation as observed in the truncated BsFapR-malonyl-CoA
complex structure, as well as in a number of acyl-CoA-binding
proteins harboring the “hot-dog” fold (Albanesi et al., 2013).
In this way, the ligand malonate is completely occluded from
the bulk solvent. The charged carboxylate group of malonate is
neutralized at the bottom of the binding pocket by a specific
interaction with an arginine residue. Upon engagement of this
arginine in effector binding, a local reorganization is triggered
that ultimately leads to surface reshaping and stabilization of
the non-productive conformation, thus preventing DNA binding
(Albanesi et al., 2013). On the other hand, the adenosine-
3′-phosphate moiety of malonyl-CoA is largely exposed to
the solvent making no specific contacts with the protein.
This implies that SaFapR specifically recognizes the malonyl-
phosphopantetheine moiety of the ligand (Albanesi et al., 2013)
in agreement with the fact that either malonyl-CoA or malonyl-
acyl carrier protein (malonyl-ACP) can both function as effector
molecules (Martinez et al., 2010). A detailed comparison of
the complexes of full-length SaFapR and the truncated form
of BsFapR (lacking the DBDs) with malonyl-CoA revealed a
conserved structural arrangement of the EBD core and ligand
binding effects. Altogether, the structural alignment indicates
an identical mode of malonyl-CoA binding and also the
conservation of the DBD–αL–EBD interactions required to
stabilize the FapR-malonyl-CoA complex as observed in the
SaFapR model (Figure 2B) (Albanesi et al., 2013).
The Structure of Full-Length SaFapR
Full-length SaFapR was also crystallized in the absence of
ligands (apo-SaFapR) and two crystals forms were obtained
(Albanesi et al., 2013). In the different structures, most of the
crystallographic independent repressor protomers exhibited the
non-productive quaternary arrangement with helix αL bound
to the lateral face of the EBD, as observed in the structure
of SaFapR in complex with malonyl-CoA (Figure 2B), strongly
suggesting that in solution the apo-protein would also display
this conformation (Albanesi et al., 2013). However, in one of the
crystal forms, the helix αL and the associated DBD of one SaFapR
protomer could not be modeled due to their high flexibility and
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the corresponding first visible residues connecting the helix αL
with the EBD exhibited a similar conformation to that found
for one subunit of the repressor in the asymmetric SaFapR-
DNA complex (Figure 2A) (Albanesi et al., 2013). These facts
and other crystal parameters (like the extensive crystal contact
engagement, the high temperature factors or even the partial
disorder displayed by the helix-turn-helix motifs) suggested that
alternative conformational states of SaFapR, marked by flexible
DBDs, would coexist in solution (Albanesi et al., 2013).
Structural Transitions along the FapR
Regulation Cycle
The structural snapshots of full-length SaFapR along its
regulation cycle revealed distinct quaternary arrangements
for the DNA-bound (relaxed) and the malonyl-CoA-bound
(tense) forms of the repressor, with the linker αL involved in
different protein-protein interactions in each case, highlighting a
functional switch entailing a large-scale structural rearrangement
(Figure 2C) (Albanesi et al., 2013). Indeed, the amphipathic αL,
that in the tense state binds through its hydrophobic face to
the protein EBD (Figure 2B), dissociates and moves ∼30 Å to
finally interact with αL from the second protomer (αL′) and
with DNA in the relaxed state (Figure 2A) (Albanesi et al.,
2013). Furthermore, the structural analysis of apo-SaFapR in two
distinct crystal forms also showed that the ligand-free repressor
species can populate both, the tense and relaxed conformational
states (Albanesi et al., 2013). This suggested that DNA would
promote and stabilize the relaxed form of the repressor while
an increment in the intracellular concentration of malonyl-
CoA would not only trigger the structural changes leading to
disruption of the repressor-operator complex but would also
drive a shift of the ligand-free SaFapR population toward the
tense form (Albanesi et al., 2013).
THE FapR SYSTEM AS A TARGET FOR
NEW ANTIBACTERIAL DRUGS
As discussed above, bacterial fatty acid biosynthesis is essential
for the formation of biological membranes. Indeed, the
importance of the pathway in bacterial physiology is highlighted
by the existence of multiple natural products that target different
points in this biosynthetic route (Parsons and Rock, 2011). The
emergence of resistance to most clinically deployed antibiotic
has stimulated considerable interest in finding new therapeutics,
leading to a significant effort in academia and industry to
develop antibiotic that target individual proteins in fatty acid
biosynthesis. One concern about such drugs is that fatty acids
are abundant in the mammalian host, raising the possibility that
fatty acid synthesis inhibitors would be bypassed in vivo (Brinster
et al., 2009). Although all bacteria studied to date are capable
of incorporating extracellular fatty acids into their membranes,
recent research shows that, opposite to what happens in
Streptococcus pneumoniae (Parsons et al., 2011), exogenous fatty
acids cannot circumvent the inhibition of FASII in S. aureus and
many major human pathogens (Yao and Rock, 2015).
Notably, disruption of FapR-malonyl-CoA interactions by
structure-based amino acid substitutions in S. aureus leads to
permanent repression of fatty acid and phospholipid synthesis,
which is lethal and cannot be overcome by addition of exogenous
fatty acids (Albanesi et al., 2013), as observed with antibiotics
targeting FASII (Parsons et al., 2011). Thus, the distinctive mode
of action of FapR together with the promising in vivo results
highlight lipid homeostasis and the FapR system as a propitious
target for the development of new drugs against Gram-positive
bacteria.
THE FapR SYSTEM AS A
BIOTECHNOLOGICAL TOOL
In the last few years, a number of research groups have
taken advantage of the unique properties of FapR to design
and construct malonyl-CoA biosensors. Recently, a FapR-based
malonyl-CoA sensor has been developed to detect changes of
malonyl-CoA flux in livingmammalian cells (Ellis andWolfgang,
2012). After codon optimization, FapR from B. subtilis was
fused to VP16, a viral transcriptional activator. The VP16 fusion
converted FapR from a bacterial transcriptional repressor into
a transcriptional activator in the absence of malony-CoA. The
FapR operator sequence (fapO) was then multimerized and
cloned upstream of a minimal promoter driving a reporter
gene. This FapR-based malonyl-CoA biosensor was proven to be
transcriptionally regulated by malonyl-CoA in mammalian cells
and the reporter gene activity was demonstrated to be correlated
with the intracellular levels of this effector molecule (Ellis and
Wolfgang, 2012). This biosensor was then used to identify several
novel kinases that when expressed in COS1 cells (a fibroblast-
like cell line derived from monkey kidney tissue) promoted an
increment of malonyl-CoA concentrations. In particular, it was
shown that the expression of one of these kinases, LIMK1, altered
both fatty acid synthesis and fatty acid oxidation rates. Thus, this
simplemalonyl-CoA responsive biosensor proved to be useful for
the study of lipid metabolism in live mammalian cells and the
identification of a novel metabolic regulator (Ellis andWolfgang,
2012).
Two independent groups reported the development of a
malonyl-CoA biosensor based on the FapR system of B. subtilis
in the yeast Saccharomyces cerevisiae (Li et al., 2015; David
et al., 2016). In both cases FapR was directed to the nucleus
where it acted as a repressor on a synthetic promoter
containing the FapR-operator site in optimized positions. The
biosensors were validated and showed to reflect the change
of intracellular malonyl-CoA concentrations. Both groups then
used the malonyl-CoA biosensor to improve the production of
the biotechnological valuable intermediate 3-hydroxypropionic
acid (3-HP), which serves as the precursor to a series of
chemicals, such as acrylates. Each group followed a different
strategy to achieve this goal. Li et al. (2015) used the
malonyl-CoA biosensor to screen a genome-wide overexpression
library resulting in the identification of two novel gene
targets that raised the intracellular malonyl-CoA concentration.
Furthermore, they overexpressed the identified genes in a yeast
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strain carrying a bifunctional enzyme, caMCR, from Chloroflexus
aurantiacus that acts both, as an NADPH-dependent malonyl-
CoA reductase and as a 3-hydroxypropionate dehydrogenase,
converting malonyl-CoA to malonic-semialdehyde first and then
to 3-HP. Interestingly, the authors found that the recombinant
yeast strains producing higher amounts of malonyl-CoA showed
over 100% improvement of 3-HP production (Li et al., 2015).
Using a different approach, David et al. (2016) expressed the
gene coding for caMCR (mcrCa) under the control of the FapR-
based biosensor. This self-regulated system gradually expressed
the mcrCa gene depending on the available concentration of
malonyl-CoA. Subsequently, in order to increase the malonyl-
CoA supply for 3-HP production, the authors (David et al.,
2016) implemented a hierarchical dynamic control system using
the PHXT1 promoter to render FAS1 expression dependent on
the concentration of glucose. FAS1 codes for the β-subunit of
the fatty acid synthase complex in S. cerevisiae, while the α-
subunit is encoded by FAS2. The expression of FAS1 and FAS2
is co-regulated, implying a coordinated up—or downregulation
of the entire FAS system. Hence, when the external glucose
concentration is low the PHXT1 promoter is repressed and FAS1
gene expression is downregulated, decreasing the consumption of
malonyl-CoA in fatty acid biosynthesis. As a consequence, there
is an increment in the intracellular malonyl-CoA concentration
available for 3-HP production. Using this hierarchical two-level
control and the fine-tuning of mcrCa gene expression, a 10-fold
increase in 3-HP production was obtained (David et al., 2016).
Aliphatic hydrocarbons produced by microorganisms
constitute a valuable source of renewable fuel so, in order to
satisfy the global energy demand, high productivity and yields
become essential parameters to achieve. Nowadays big efforts
in microbial biofuel production are dedicated to build efficient
metabolic pathways for the production of a variety of fatty
acid-based fuels. In this regard, two studies were reported
on the implementation of the FapR system in E. coli, which
originally lacks the fap regulon, for the improvement of fatty
acid production (Xu et al., 2014a; Liu et al., 2015). Malonyl-CoA,
produced by ACC (Figure 1), is the rate limiting precursor for
the synthesis of fatty acids. The E. coli ACC is composed of four
subunits: a biotin carboxyl carrier protein, a biotin carboxylase,
and two carboxyltransferase subunits. The overexpression of
the genes coding for the ACC subunits improves fatty acids
production but at the same time is toxic to the cells (Davis
et al., 2000; Zha et al., 2009). To overcome this drawback,
Liu et al. designed a strategy for increasing malonyl-CoA
synthesis reducing the toxicity provoked by the concomitant
acc overexpression (Liu et al., 2015). To this end, they built a
negative regulatory system for the acc genes based on the ability
of FapR to respond to the level of malonyl-CoA. Their goal was
to promote a reduction in acc expression when malonyl-CoA
levels were high and induce it when the malonyl-CoA levels
were low. This required the design of a rewired system to
create a negative feedback circuit. To this end, the B. subtilis
fapR gene was cloned into E. coli using a low copy number
plasmid under the control of a PBAD promoter responding
to arabinose. A FapR-regulated synthetic promoter (PFR1)
was also constructed by inserting the 17-bp FapR operator
sequence into two regions flanking the−10 region of a phage
PA1 promoter. PFR1 was validated as a FapR-regulated promoter
by analyzing the expression of a fluorescent protein under its
control in response to different concentrations of malonyl-CoA
(Liu et al., 2015). To complete the circuit, the acc genes were
placed under the control of a LacI-repressive T7 promoter, PT7,
and the lacI gene was placed under the control of PFR1. Hence,
acc expression is initiated upon IPTG induction, producing
malonyl-CoA. When malonyl-CoA is accumulated in this strain,
the expression from PFR1 will turn on producing LacI, which in
turn down-regulates acc, decreasing the malonyl-CoA synthesis
rate. Using this approach, it was demonstrated that the negative
feed-back circuit alleviated growth inhibition caused by either
ACC overexpression or malonyl-CoA accumulation (Liu et al.,
2015). In addition, this method was used for improving fatty
acid titers and productivity and, in principle, could be extended
to the production of other chemicals that use malonyl-CoA as
precursor (Liu et al., 2015). Xu et al. (2014b) also constructed a
malonyl-CoA sensing device by incorporating fapO into a hybrid
T7 promoter that was shown to be able to respond to a broad
range of intracellular malonyl-CoA concentrations, inducing the
expression from the T7 promoter at increasing concentrations of
the effector molecule. Interestingly, this group then discovered
that the FapR protein could activate gene expression from the
native E. coli promoter PGAP in the absence of malonyl-CoA, that
malonyl-CoA inhibits this activation, and that the dynamic range
(in response to malonyl-CoA) can be tuned by incorporating
fapO sites within the PGAP promoter (Xu et al., 2014a). In order
to improve fatty acid production, the genes coding for the ACC
were then put under the control of the PGAP promoter and the
fatty acid synthase (fabADGI genes) and the soluble thioesterase
tesA′ were placed under the control of the T7-based malonyl-
CoA sensor promoter. Upon constitutive FapR expression, the
resulting genetic circuit provided dynamic pathway control that
improved fatty acid production relative to the “uncontrolled”
strains (Xu et al., 2014a). Taken together, these studies highlight
FapR as a powerful responsive regulator for optimization and
efficient production of malonyl-CoA-derived compounds.
CONCLUSIONS AND PERSPECTIVES
FapR is a global transcriptional repressor of lipid synthesis highly
conserved in Gram-positive bacteria. Notably, the activity of
this repressor is controlled by malonyl-CoA, the product of the
first dedicated step of fatty acid biosynthesis, converting FapR
into a paradigm of a feed-forward-modulated regulator of lipid
metabolism. The activity of other well-characterized bacterial
lipid regulators, like FadR of E. coli (van Aalten et al., 2001) or
the TetR-like P. aeruginosa DesT (Miller et al., 2010), is feedback
controlled by the long-acyl chain-end products of the FASII
pathway (Zhang and Rock, 2009; Parsons and Rock, 2013). The
EBDs of these proteins, frequently exhibit an α-helical structure
with a relaxed specificity for long-chain acyl-CoA molecules,
possibly because helix-helix interactions are permissive enough
to constitute a platform for the evolution of a binding site for
fatty acids of diverse chain lengths (Albanesi et al., 2013). In
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contrast, the feed-forward regulation mechanism of the FapR
repressor family, which implies the recognition of the upstream
biosynthetic intermediate malonyl-CoA, requires a high effector-
binding specificity. In FapR, this high specificity is achieved by
confining the charged malonyl group into a quite rigid internal
binding pocket, and may be the reason why the “hot-dog”
fold was recruited for this function (Albanesi et al., 2013). It
is important to note that organisms using the FapR pathway
could also count on a complementary feed-back regulatory loop
operating at a biochemical level, for instance by controlling the
synthesis of malonyl-CoA (Paoletti et al., 2007). If this is proven,
it would imply that FapR-containing bacteria finely tune lipid
homeostasis by feed-back and feed-forward mechanisms, as it
indeed happens in higher organisms ranging from the nematode
Caenorhabditis elegans to humans (Raghow et al., 2008).
Human health and life quality have significantly improved
with the discovery of antibiotics for the treatment of infectious
bacterial diseases. However, the emergence of bacterial resistance
to all antimicrobials in clinical use (Levy and Marshall, 2004;
Davies and Davies, 2010) has caused infectious bacterial diseases
to re-emerge as a serious threat to human health. This scenario
highlights the need to develop new strategies to combat bacterial
pathogens. FapR controls the expression of many essential
genes for bacteria not only involved in fatty acids but also
in phospholipid synthesis. It has been experimentally shown
that the presence of mutant variants of FapR unable to bind
malonyl-CoA result lethal for bacteria (even in the presence of
exogenous fatty acids), as the regulator remains permanently
bound to DNA impeding the expression of its target genes.
These results and the existence of FapR in important human
pathogens validate FapR and lipid homeostasis as interesting
targets for the search of new antibacterial drugs. With another
perspective, the high specificity of FapR for malonyl-CoA
has allowed for the development of in vivo malonyl-CoA
sensors in diverse organisms that originally lack FapR and the
fap regulon. These sensors have been shown to function in
mammalian cells, in yeast and in bacteria responding accurately
to the intracellular variations in the concentration of malonyl-
CoA. The different FapR-based-malonyl-CoA biosensors were
constructed following alternative strategies and used with a broad
range of purposes focused on biological processes involving
malonyl-CoA, including signaling mechanisms and metabolic
engineering. Malonyl-CoA is the precursor of many industrial-
valuable compounds like fatty acids, 3-hydroxypropionic acid,
polyketides, and flavonoids, since they can be used as or
converted to biofuels, commodity chemicals, fine chemicals, and
drugs. Due to the success in the implementation of the FapR-
based biosensors to improve the productivity and yields of the
production of several malonyl-CoA-derived compounds, it is
expected that new biotechnological applications of the FapR
system emerge in the short term.
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